Relative Effectiveness Assessment of Pharmaceuticals: Similarities and Differences in 29 Jurisdictions
Open Access
- 22 June 2012
- journal article
- research article
- Published by Elsevier BV in Value in Health
- Vol. 15 (6), 954-960
- https://doi.org/10.1016/j.jval.2012.04.010
Abstract
No abstract availableKeywords
Funding Information
- European Commission
This publication has 16 references indexed in Scilit:
- Relative effectiveness and the European pharmaceutical marketThe European Journal of Health Economics, 2011
- International Comparison of Comparative Effectiveness Research in Five JurisdictionsPharmacoEconomics, 2010
- Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payersNature Reviews Drug Discovery, 2010
- Comparative Effectiveness Research and Evidence‐Based Health Policy: Experience from Four CountriesThe Milbank Quarterly, 2009
- Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviewsBMJ, 2009
- Direct versus indirect comparisons: A summary of the evidenceInternational Journal of Technology Assessment in Health Care, 2008
- Composite Endpoints for Clinical TrialsInternational Journal of Pharmaceutical Medicine, 2007
- Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorizationBritish Journal of Clinical Pharmacology, 2006
- Centralized Drug Review Processes In Australia, Canada, New Zealand, And The United KingdomHealth Affairs, 2006
- Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analysesBMJ, 2003